¹H-MR Spectroscopy in the Human Spinal Cord

REFERENCES

1. 1.↵
   1. de Graaf RA

   . In Vivo NMR Spectroscopy: Principles and Techniques. 2nd ed. Chichester, West Sussex, UK: Wiley-Interscience; 2008:592
2. 2.↵
   1. Preul MC,
   2. Caramanos Z,
   3. Collins DL,
   4. et al

   . Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323–25

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Kim YG,
   2. Choi GH,
   3. Kim DH,
   4. et al

   . In vivo proton magnetic resonance spectroscopy of human spinal mass lesions. J Spinal Disord Tech 2004;17:405–11

   CrossRefPubMed
4. 4.↵
   1. Kollias S,
   2. Goldstein R,
   3. Cogen P,
   4. et al

   . Prenatally detected myelomeningoceles: sonographic accuracy in estimation of the spinal level. Radiology 1992;185:109–12

   PubMedWeb of Science
5. 5.↵
   1. Cooke FJ,
   2. Blamire AM,
   3. Manners DN,
   4. et al

   . Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord. Magn Reson Med 2004;51:1122–28

   CrossRefPubMed
6. 6.↵
   1. Loth F,
   2. Yardimci MA,
   3. Alperin N

   . Hydrodynamic modeling of cerebrospinal fluid motion within the spinal cavity. J Biomech Eng 2001;123:71–79

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Figley CR,
   2. Stroman PW

   . Investigation of human cervical and upper thoracic spinal cord motion: implications for imaging spinal cord structure and function. Magn Reson Med 2007;58:185–89

   CrossRefPubMed
8. 8.↵
   1. Kreis R

   . Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 2004;17:361–81

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Ciccarelli O,
   2. Wheeler-Kingshott CA,
   3. McLean MA,
   4. et al

   . Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007;130:2220–31

   Abstract/FREE Full Text
10. 10.↵
    1. Gómez-Ansón B,
    2. MacManus DG,
    3. Parker GJ,
    4. et al

    . In vivo 1H-magnetic resonance spectroscopy of the spinal cord in humans. Neuroradiology 2000;42:515–17

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Holly LT,
    2. Freitas B,
    3. McArthur DL,
    4. et al

    . Proton magnetic resonance spectroscopy to evaluate spinal cord axonal injury in cervical spondylotic myelopathy. J Neurosurg Spine 2009;10:194–200

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Kendi AT,
    2. Tan FU,
    3. Kendi M,
    4. et al

    . MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiol 2004;46:764–69

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Rapalino O,
    2. Law M,
    3. Salibi N,
    4. et al

    . Metabolite changes from MR spectroscopy in the cervical spinal cord in patients with cervical spondylosis. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Seattle, Washington. May 6–12, 2006:3139
14. 14.↵
    1. Callot V,
    2. Le Fur Y,
    3. Ranjeva JP,
    4. et al

    . Spinal cord diffusion tensor imaging (DTI) and 1H-MR spectroscopy (MRS) at 1.5T and 3T. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Stockholm, Sweden. May 1–7, 2010:2453
15. 15.↵
    1. Rapalino O,
    2. Law M,
    3. Salibi N,
    4. et al

    . In vivo MR spectroscopy in the human cervical spinal cord at 1.5 and 3 Tesla. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Seattle, Washington. May 6–12, 2006:3138
16. 16.↵
    1. Blamire AM,
    2. Cader S,
    3. Lee M,
    4. et al

    . Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy. Magn Reson Med 2007;58:880–85

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Henning A,
    2. Schar M,
    3. Kollias SS,
    4. et al

    . Quantitative magnetic resonance spectroscopy in the entire human cervical spinal cord and beyond at 3T. Magn Reson Med 2008;59:1250–58

    CrossRefPubMed
18. 18.↵
    1. Hock A,
    2. Henning A,
    3. Schär M,
    4. et al

    . ECG-triggered FASTERMAP shimming allows for reproducible shim convergence in spinal cord spectroscopy. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Stockholm, Sweden. May 1–7, 2010:5042
19. 19.↵
    1. Hock A,
    2. MacMillan EL,
    3. Fuchs A,
    4. et al

    . Non-water suppressed proton MR spectroscopy allows spectral quality improvement in the human cervical spinal cord. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Québec, Canada. May 7–13, 2011:406
20. 20.↵
    1. Marliani AF,
    2. Clementi V,
    3. Albini-Riccioli L,
    4. et al

    . Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 2010;31:180–84

    Abstract/FREE Full Text
21. 21.↵
    1. Marliani AF,
    2. Clementi V,
    3. Albini-Riccioli L,
    4. et al

    . Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 Tesla. Magn Reson Med 2007;57:160–63

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Carew JD,
    2. Nair G,
    3. Pineda-Alonso N,
    4. et al

    . Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12:185

    CrossRefPubMed
23. 23.↵
    1. de Vita E,
    2. Kachramanoglou C,
    3. Wheeler-Kingshott CA,
    4. et al

    . Spinal cord 1H-MR spectroscopy in patients after brachial plexus root re-implantation. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Montreal, Québec, Canada. May 7–13, 2011:4290
24. 24.↵
    1. Dubey P,
    2. Smith M,
    3. Bonekamp D,
    4. et al

    . Proton MR spectroscopic imaging of the human cervical spine at 3 Tesla. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Miami Beach, Florida. May 7–13, 2005:812
25. 25.↵
    1. Dydak U,
    2. Kollias S,
    3. Schär M,
    4. et al

    . MR spectroscopy in different regions of the spinal cord and in spinal cord tumors. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Miami Beach, Florida. May 7–13, 2005:813
26. 26.↵
    1. Edden RA,
    2. Bonekamp D,
    3. Smith MA,
    4. et al

    . Proton MR spectroscopic imaging of the medulla and cervical spinal cord. J Magn Reson Imaging 2007;26:1101–05

    CrossRefPubMed
27. 27.↵
    1. Pineda-Alonso N,
    2. Benatar M,
    3. Smith R,
    4. et al

    . Reliability of 1H-MRS of the cervical spine at 3T. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Toronto, Ontario, Canada. May 3–9, 2008:02287
28. 28.↵
    1. Pineda-Alonso N,
    2. Benatar M,
    3. Hu X,
    4. et al

    . Proton magnetic resonance spectroscopy (1H-MRS) on the spinal cord in amyotrophic lateral sclerosis (ALS) at 3T. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Honolulu, Hawaii. April 18–24, 2009:3325
29. 29.↵
    1. Hock A,
    2. Fuchs A,
    3. Boesiger P,
    4. et al

    . Electrocardiogram-triggered higher order projection based B0-shimming allows for fast and reproducible shim convergence in spinal cord 1H magnetic resonance spectroscopy. NMR Biomed. 2013;26:329–35

    CrossRefPubMed
30. 30.↵
    1. Hock A,
    2. MacMillan EL,
    3. Fuchs A,
    4. et al

    . Non-water-suppressed proton MR spectroscopy improves spectral quality in the human spinal cord. Magn Reson Med 2013;69:1253–60

    CrossRefPubMed
31. 31.↵
    1. Henning A,
    2. Koning W,
    3. Fuchs A,
    4. et al

    . 1H MRS in the human spinal cord at 7T using a combined RF shimming and travelling wave transmit approach. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Victoria, Australia. May 5–11, 2012:0711
32. 32.↵
    1. Bottomley PA

    . Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987;508:333–48

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Hock A,
    2. Fuchs A,
    3. Boesiger P,
    4. et al

    . Spinal cord MR spectroscopy in neoplastic lesions. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Victoria, Australia. May 5–11, 2012:0838
34. 34.↵
    1. Frahm J,
    2. Merboldt KD,
    3. Hänicke W

    . Localized proton spectroscopy using stimulated echoes. J Magn Reson 1987;72:502–08

    Web of Science
35. 35.↵
    1. Pijnappel WW,
    2. van den Boogaart A,
    3. de Beer R,
    4. et al

    . SVD-based quantification of magnetic resonance signals. J Magn Reson 1992;97:122–34

    CrossRefWeb of Science
36. 36.↵
    1. Hock A,
    2. Fuchs A,
    3. MacMillan EL,
    4. et al

    . Scyllo-inositol detection in the human spinal cord. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Victoria, Australia. May 5–11, 2012:1815
37. 37.↵
    1. Hock A,
    2. Petrou N,
    3. Zweers P,
    4. et al

    . MR spectroscopy in the spinal cord of patients with traumatic injuries. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Victoria, Australia. May 5–11, 2012:1047
38. 38.↵
    1. Boer VO,
    2. van de Bank BL,
    3. van Vliet G,
    4. et al

    . Direct B0 field monitoring and real time B0 field updating in the human breast at 7 Tesla. Magn Reson Med 2012;67:586–91

    CrossRefPubMed
39. 39.↵
    1. Gruetter R

    . Automatic, localized in vivo adjustment of all first-and second-order shim coils. Magn Reson Med 1993;29:804–11

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Gruetter R,
    2. Boesch C

    . Fast, noniterative shimming of spatially localized signals. In vivo analysis of the magnetic field along axes. J Magn Reson 1992;96:323–34
41. 41.↵
    1. Gruetter R,
    2. Tkáč I

    . Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med 2000;43:319–23

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Shen J,
    2. Rycyna RE,
    3. Rothman DL

    . Improvements on an in vivo automatic shimming method [FASTERMAP]. Magn Reson Med 1997;38:834–39

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Haase A,
    2. Frahm J,
    3. Hanicke W,
    4. et al

    . 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341–44

    CrossRefPubMedWeb of Science
44. 44.↵
    1. Tkac I,
    2. Starcuk Z,
    3. Choi IY,
    4. et al

    . In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 1999;41:649–56

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Dreher W,
    2. Leibfritz D

    . New method for the simultaneous detection of metabolites and water in localized in vivo 1H nuclear magnetic resonance spectroscopy. Magn Reson Med 2005;54:190–95

    CrossRefPubMed
46. 46.↵
    1. Smith MA,
    2. Gillen J,
    3. McMahon MT,
    4. et al

    . Simultaneous water and lipid suppression for in vivo brain spectroscopy in humans. Magn Reson Med 2005;54:691–96

    CrossRefPubMed
47. 47.↵
    1. Klose U

    . In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990;14:26–30

    PubMedWeb of Science
48. 48.↵
    1. Heinzer-Schweizer S,
    2. De Zanche N,
    3. Pavan M,
    4. et al

    . In-vivo assessment of tissue metabolite levels using 1H MRS and the Electric REference To access In vivo Concentrations (ERETIC) method. NMR in Biomedicine 2010;23:406–13

    PubMed
49. 49.↵
    1. Provencher SW

    . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–79

    CrossRefPubMedWeb of Science
50. 50.↵
    1. Stefan D,
    2. Di Cesare F,
    3. Andrasescu A,
    4. et al

    . Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package. Measurement Science and Technology 2009;20:104035

    CrossRef